N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide

C96H98F10N16O18 — CID 159594367

IUPACN-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
SMILESCOc1cc2c(cc1N1CCCOC1=O)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2CCCO.COc1cc2c(cc1N1CCCOC1=O)nc(NC(=O)c1cccc(C(F)F)c1)n2CCCO.O=C(Nc1nc2cc(N3CCOCC3=O)c(C3CC3)cc2n1CCCO)c1cccc(C(F)(F)F)c1.O=C(Nc1nc2cc(N3CCOCC3=O)c(C3CC3)cc2n1CCCO)c1cccc(C(F)F)c1
InChIInChI=1S/C25H25F3N4O4.C25H26F2N4O4.C23H23F3N4O5.C23H24F2N4O5/c26-25(27,28)17-4-1-3-16(11-17)23(35)30-24-29-19-13-20(31-8-10-36-14-22(31)34)18(15-5-6-15)12-21(19)32(24)7-2-9-33;26-23(27)16-3-1-4-17(11-16)24(34)29-25-28-19-13-20(30-8-10-35-14-22(30)33)18(15-5-6-15)12-21(19)31(25)7-2-9-32;1-34-19-13-17-16(12-18(19)30-8-4-10-35-22(30)33)27-21(29(17)7-3-9-31)28-20(32)14-5-2-6-15(11-14)23(24,25)26;1-33-19-13-17-16(12-18(19)29-8-4-10-34-23(29)32)26-22(28(17)7-3-9-30)27-21(31)15-6-2-5-14(11-15)20(24)25/h1,3-4,11-13,15,33H,2,5-10,14H2,(H,29,30,35);1,3-4,11-13,15,23,32H,2,5-10,14H2,(H,28,29,34);2,5-6,11-13,31H,3-4,7-10H2,1H3,(H,27,28,32);2,5-6,11-13,20,30H,3-4,7-10H2,1H3,(H,26,27,31)
InChIKeyMKQJUBXBIPAAMT-UHFFFAOYSA-N
MW1953.91 g/mol
LogP15.79
Rot. Bonds30

About N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide

N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide (PubChem CID 159594367) has the molecular formula C96H98F10N16O18 and a molecular weight of 1953.91 g/mol. Its IUPAC name is N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide.

Molecular Properties

Compound NameN-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
PubChem CID159594367
Molecular FormulaC96H98F10N16O18
Molecular Weight1953.91 g/mol
Exact Mass1952.71
IUPAC NameN-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide
SMILESCOc1cc2c(cc1N1CCCOC1=O)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2CCCO.COc1cc2c(cc1N1CCCOC1=O)nc(NC(=O)c1cccc(C(F)F)c1)n2CCCO.O=C(Nc1nc2cc(N3CCOCC3=O)c(C3CC3)cc2n1CCCO)c1cccc(C(F)(F)F)c1.O=C(Nc1nc2cc(N3CCOCC3=O)c(C3CC3)cc2n1CCCO)c1cccc(C(F)F)c1
InChIInChI=1S/C25H25F3N4O4.C25H26F2N4O4.C23H23F3N4O5.C23H24F2N4O5/c26-25(27,28)17-4-1-3-16(11-17)23(35)30-24-29-19-13-20(31-8-10-36-14-22(31)34)18(15-5-6-15)12-21(19)32(24)7-2-9-33;26-23(27)16-3-1-4-17(11-16)24(34)29-25-28-19-13-20(30-8-10-35-14-22(30)33)18(15-5-6-15)12-21(19)31(25)7-2-9-32;1-34-19-13-17-16(12-18(19)30-8-4-10-35-22(30)33)27-21(29(17)7-3-9-31)28-20(32)14-5-2-6-15(11-14)23(24,25)26;1-33-19-13-17-16(12-18(19)29-8-4-10-34-23(29)32)26-22(28(17)7-3-9-30)27-21(31)15-6-2-5-14(11-15)20(24)25/h1,3-4,11-13,15,33H,2,5-10,14H2,(H,29,30,35);1,3-4,11-13,15,23,32H,2,5-10,14H2,(H,28,29,34);2,5-6,11-13,31H,3-4,7-10H2,1H3,(H,27,28,32);2,5-6,11-13,20,30H,3-4,7-10H2,1H3,(H,26,27,31)
InChIKeyMKQJUBXBIPAAMT-UHFFFAOYSA-N
XLogP15.79
TPSA405.22 Ų
H-Bond Donors8
H-Bond Acceptors26
Rotatable Bonds30
Heavy Atoms140
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001953.91
LogP ≤ 515.79
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1026

Analyze N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide?
The IUPAC name of N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide (CID 159594367) is N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide is COc1cc2c(cc1N1CCCOC1=O)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2CCCO.COc1cc2c(cc1N1CCCOC1=O)nc(NC(=O)c1cccc(C(F)F)c1)n2CCCO.O=C(Nc1nc2cc(N3CCOCC3=O)c(C3CC3)cc2n1CCCO)c1cccc(C(F)(F)F)c1.O=C(Nc1nc2cc(N3CCOCC3=O)c(C3CC3)cc2n1CCCO)c1cccc(C(F)F)c1.
What is the InChIKey of N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide?
The InChIKey is MKQJUBXBIPAAMT-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H25F3N4O4.C25H26F2N4O4.C23H23F3N4O5.C23H24F2N4O5/c26-25(27,28)17-4-1-3-16(11-17)23(35)30-24-29-19-13-20(31-8-10-36-14-22(31)34)18(15-5-6-15)12-21(19)32(24)7-2-9-33;26-23(27)16-3-1-4-17(11-16)24(34)29-25-28-19-13-20(30-8-10-35-14-22(30)33)18(15-5-6-15)12-21(19)31(25)7-2-9-32;1-34-19-13-17-16(12-18(19)30-8-4-10-35-22(30)33)27-21(29(17)7-3-9-31)28-20(32)14-5-2-6-15(11-14)23(24,25)26;1-33-19-13-17-16(12-18(19)29-8-4-10-34-23(29)32)26-22(28(17)7-3-9-30)27-21(31)15-6-2-5-14(11-15)20(24)25/h1,3-4,11-13,15,33H,2,5-10,14H2,(H,29,30,35);1,3-4,11-13,15,23,32H,2,5-10,14H2,(H,28,29,34);2,5-6,11-13,31H,3-4,7-10H2,1H3,(H,27,28,32);2,5-6,11-13,20,30H,3-4,7-10H2,1H3,(H,26,27,31).
What are the key properties of N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide?
N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide has a molecular weight of 1953.91 g/mol, XLogP of 15.79, 30 rotatable bonds, 8 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(difluoromethyl)benzamide;N-[6-cyclopropyl-1-(3-hydroxypropyl)-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]benzamide;N-[1-(3-hydroxypropyl)-6-methoxy-5-(2-oxo-1,3-oxazinan-3-yl)benzimidazol-2-yl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 159594367), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).